Post-COVID-19 multisystem inflammatory syndrome: an evolving concept

被引:0
作者
Luiz Staub, Henrique [1 ]
Portella Staub, Lia [1 ]
机构
[1] Pontificia Univ Catolica Rio Grande do Sul PUCRS, Escola Med, Porto Alegre, RS, Brazil
关键词
multisystem inflammatory syndrome; Kawasaki disease; SARS-CoV-2; COVID-19; KAWASAKI-DISEASE; COVID-19; CHILDREN;
D O I
10.15448/1980-6108.2022.1.42436
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
INTRODUCTION: A potential association of COVID-19 with inflammatory and autoimmune phenomena opens a new chapter in clinical practice. Among several inflammatory conditions described in the post-COVID-19 context, Kawasaki disease and a new condition named multisystem inflammatory syndrome stand out. AIMS: To review, in a practical and concise way, the concept and diagnostic criteria of multisystem inflammatory syndrome, the overlaps with Kawasaki disease, as well as the immunopathogenesis and treatment of this new and intriguing condition. METHODS: Literature review available in the Pubmed database, with emphasis on systematic reviews with meta-analyses. RESULTS: The multisystem inflammatory syndrome is a post-viral, multiorgan hyperinflammatory disorder. The condition is primarily pediatric, and the first cases were reported in England in May 2020. Diagnostic criteria are still imprecise, and include some Kawasaki disease-like manifestations. However, multisystem inflammatory syndrome differs from Kawasaki disease by usually affecting children above five years of age and of black or hispanic races; in clinical terms, it is distinguished by the high frequency of gastroenteropathy, cardiomyopathy and shock. Differential diagnosis includes bacterial sepsis, macrophage activation syndrome, and systemic forms of rheumatoid arthritis. An overexpression of interferons and other inflammatory cytokines pathogenically characterize the multisystem inflammatory syndrome. The disease is, as a rule, responsive to intensive care, steroids, intravenous immunoglobulin, and immunobiologics. CONCLUSIONS: Multisystem inflammatory syndrome is a new and complex hyperinflammatory condition associated with previous exposure to SARS-CoV-2. It shows interesting interfaces with Kawasaki disease. Despite the recent description, the literature is already quantitatively robust, and some pending issues in immunopathogenesis, diagnostic criteria and therapy should be shortly clarified.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 53 条
  • [1] American Heart Association, KAWASAKI DISEASE
  • [2] [Anonymous], 2019, Rapid risk assessment: Zika virus transmission worldwide
  • [3] Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)
    Ayusawa, M
    Sonobe, T
    Uemura, S
    Ogawa, S
    Nakamura, Y
    Kiyosawa, N
    Ishii, M
    Harada, K
    [J]. PEDIATRICS INTERNATIONAL, 2005, 47 (02) : 232 - 234
  • [4] The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection
    Berardicurti, Onorina
    Conforti, Alessandro
    Ruscitti, Piero
    Cipriani, Paola
    Giacomelli, Roberto
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (12) : 1205 - 1215
  • [5] Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey
    Cattalini, Marco
    Della Paolera, Sara
    Zunica, Fiammetta
    Bracaglia, Claudia
    Giangreco, Manuela
    Verdoni, Lucio
    Meini, Antonella
    Sottile, Rita
    Caorsi, Roberta
    Zuccotti, Gianvincenzo
    Fabi, Marianna
    Montin, Davide
    Meneghel, Alessandra
    Consolaro, Alessandro
    Dellepiane, Rosa Maria
    Maggio, Maria Cristina
    La Torre, Francesco
    Marchesi, Alessandra
    Simonini, Gabriele
    Villani, Alberto
    Cimaz, Rolando
    Ravelli, Angelo
    Taddio, Andrea
    [J]. PEDIATRIC RHEUMATOLOGY, 2021, 19 (01)
  • [6] Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children
    Chen, Men-Ren
    Kuo, Ho-Chang
    Lee, Yann-Jinn
    Chi, Hsin
    Li, Sung Chou
    Lee, Hung-Chang
    Yang, Kuender D.
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [7] Cherqaoui B, 2021, RHEUMATOLOGY, V60, P4530, DOI [10.1093/rheumatology/keab026, DOI 10.1093/RHEUMATOLOGY/KEAB026]
  • [8] Kawasaki disease
    de Castro, Patricia Aparecida
    Ferreira Urbano, Lilian Mendes
    Carvalho Costa, Izelda Maria
    [J]. ANAIS BRASILEIROS DE DERMATOLOGIA, 2009, 84 (04) : 317 - 329
  • [9] Systemic inflammatory syndrome in COVID-19-SISCoV study: systematic review and meta-analysis
    Dhar, Debjyoti
    Dey, Treshita
    Samim, M. M.
    Padmanabha, Hansashree
    Chatterjee, Aritra
    Naznin, Parvin
    Chandra, S. R.
    Mallesh, K.
    Shah, Rutul
    Siddiqui, Shahyan
    Pratik, K.
    Ameya, P.
    Abhishek, G.
    [J]. PEDIATRIC RESEARCH, 2022, 91 (06) : 1334 - 1349
  • [10] The SARS-CoV-2 as an instrumental trigger of autoimmunity
    Dotan, Arad
    Muller, Sylviane
    Kanduc, Darja
    David, Paula
    Halpert, Gilad
    Shoenfeld, Yehuda
    [J]. AUTOIMMUNITY REVIEWS, 2021, 20 (04)